Digital evaluation of proliferative 'hotspots' of more than 16,000 cells negatively impacts Ki-67 assessment in breast carcinoma

Pathology. 2019 Apr;51(3):329-331. doi: 10.1016/j.pathol.2018.10.020. Epub 2019 Mar 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / metabolism
  • Carcinoma, Ductal, Breast / pathology*
  • Cell Proliferation / physiology*
  • Female
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen / metabolism*
  • Prognosis
  • Sensitivity and Specificity

Substances

  • Ki-67 Antigen